Best Researcher Award

Ravi Sahu – Wright State University Boonshoft School of Medicine

Ravi Sahu is a pharmacology researcher associated with Wright State University Boonshoft School of Medicine in the United States. His research profile demonstrates a consistent contribution to biomedical sciences, particularly in cancer pharmacology and molecular therapeutics. The recognition under the Best Researcher Award category reflects scholarly output, citation impact, and involvement in global research collaborations. His work has contributed to advancing understanding in cancer biology, immunotherapy, and drug repurposing strategies [1].

Abstract

This article presents an academic overview of Ravi Sahu, emphasizing his scholarly contributions in pharmacology and cancer research. His work spans experimental therapeutics, immunological pathways, and drug repurposing strategies. The evaluation is based on bibliometric indicators including citation count, h-index, and research output. The profile aligns with international standards used in academic recognition systems [2].

Keywords

Pharmacology, Cancer Research, Immunotherapy, Drug Repurposing, Molecular Biology, Oncology, Research Metrics.

Introduction

The field of pharmacology has evolved significantly with the integration of molecular biology and translational medicine. Researchers such as Ravi Sahu have contributed to bridging laboratory findings with clinical applications. His research focuses on understanding cellular signaling pathways and developing therapeutic interventions. These efforts contribute to improved treatment strategies in oncology [3].

Research Profile

The research profile of Ravi Sahu indicates substantial scholarly output with over a thousand indexed documents and a growing citation base. His work is indexed in major academic databases including Scopus and ORCID. The profile reflects interdisciplinary collaboration and sustained research productivity. These indicators are commonly used to assess academic performance globally [1].

Research Contributions

Ravi Sahu has contributed to multiple areas including cancer therapeutics, platelet-activating factor signaling, and immune checkpoint research. His publications explore mechanisms of tumor progression and therapeutic resistance. The research also includes investigations into repurposed drugs such as metformin and itraconazole. These contributions enhance understanding of treatment optimization strategies [4].

Publications

The publication record includes peer-reviewed journal articles across high-impact biomedical journals. Notable works include studies on lung cancer therapies, melanoma treatment, and molecular signaling pathways. The research demonstrates both experimental and review-based scholarship. These publications contribute to advancing scientific knowledge and clinical practices [5].

Research Impact

The research impact of Ravi Sahu is reflected through citation metrics and academic collaborations. His work has been cited in multiple interdisciplinary studies, indicating relevance across scientific domains. The h-index value highlights consistent scholarly influence. Such metrics are critical in evaluating research visibility and academic significance [2].

Award Suitability

The Best Researcher Award recognizes individuals demonstrating excellence in scientific research and innovation. Ravi Sahu’s academic record meets key criteria including publication output, citation impact, and subject expertise. His involvement in international research initiatives further strengthens his eligibility. These factors collectively support recognition at global scientific platforms [3].

Conclusion

Ravi Sahu’s contributions to pharmacology and cancer research demonstrate sustained academic excellence. His work integrates molecular insights with therapeutic applications, contributing to advancements in biomedical science. The recognition under the Best Researcher Award highlights the significance of his scholarly achievements. Continued research efforts are expected to further enhance his impact in the scientific community [4].

External Links

• ORCID Profile
• Scopus Author Profile
• Sample DOI Publication
• Award Website

References

1. Elsevier. (n.d.). Scopus author details: Ravi Sahu, Author ID 36833607800. Scopus.
   https://www.scopus.com/authid/detail.uri?authorId=36833607800

2. Sahu, R. P., Zonfa, C. E., & Thyagarajan, A. (2026). Repurposing itraconazole in combination with chemotherapy and immune checkpoint inhibitor for cancer. Medical Sciences, 14(1), 55.
   https://doi.org/10.3390/medsci14010055

3. Thyagarajan, A., Gajjar, V., & Sahu, R. P. (2025). Are metformin-based combination approaches beneficial for non-small cell lung cancer: Evidence from experimental and clinical studies. Military Medical Research, 12, 61.
   https://doi.org/10.1186/s40779-025-00649-5

4. Sahu, R. P., et al. (2025). Platelet-activating factor signaling in cancer. Journal of Applied Toxicology. Advance online publication. https://doi.org/10.1002/jat.4770

5. Sahu, R. P., et al. (2023). Melatonin in melanoma treatment. Medical Sciences, 11(1), 9.

   https://doi.org/10.3390/medsci11010009